Srinivas NR |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589592
|
BenÃtez C et al. |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. Authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589580
|
Ierardi E et al. |
Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11207512
|
Romano C et al. |
Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20148798
|
Itoh S et al. |
Inhibition of CN (protein phosphatase-2B) suppresses Ca2+-mediated acid secretion in rats. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11966520
|
Yamamoto S et al. |
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18549460
|
O'Leary JG |
Editorial: tacrolimus-how low can you go? |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589579
|
Firpi RJ et al. |
Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15113371
|
Herrlinger KR et al. |
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20175769
|
Solari S et al. |
Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28261844
|
Schwrer H et al. |
Pantoprazole and cyclosporine or tacrolimus. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11284790
|
Högenauer C et al. |
Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12940927
|
Trotter JF et al. |
Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15963078
|
Lawrance IC and Copeland TS |
Rectal tacrolimus in the treatment of resistant ulcerative proctitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18761706
|
Liberal R et al. |
Expert clinical management of autoimmune hepatitis in the real world. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28004405
|
Segal JP et al. |
Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28008631
|
Yamamoto T et al. |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040167
|
Taylor KM and Sparrow MP |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040166
|
Haagsma EB et al. |
Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12848624
|
Nakase H et al. |
Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20636704
|